Keywords: imclone, unveils, melanoma, vaccine, pharmaceuticals, reported, preclinical

ImClone unveils melanoma vaccine

Article | 27 March 2001

ImClone Pharmaceuticals has reported preclinical data on a new vaccineagainst melanoma based on recombinant hTRPx3 protein. The chimeric vaccine consists ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Antihemophilic Factor

Recombinant

Coagulation Factor VIIa

Go to drug listing